What We Mean When We Talk About Adherence in Respiratory Medicine.
Identifieur interne : 001878 ( PubMed/Corpus ); précédent : 001877; suivant : 001879What We Mean When We Talk About Adherence in Respiratory Medicine.
Auteurs : Bernard Vrijens ; Alexandra L. Dima ; Eric Van Ganse ; Job F M. Van Boven ; Michelle N. Eakin ; Juliet M. Foster ; Marijn De Bruin ; Alison Chisholm ; David PriceSource :
- The journal of allergy and clinical immunology. In practice [ 2213-2201 ]
English descriptors
- KwdEn :
- MESH :
- classification : Pulmonary Medicine.
- drug therapy : Asthma, Pulmonary Disease, Chronic Obstructive.
- Humans, Medication Adherence.
Abstract
Adequate medication adherence is key for optimal benefit of pharmacological treatments. A wealth of research has been conducted to understand and identify opportunities to intervene to improve medication adherence, but variations in adherence definitions within prior research have led to ambiguity in study findings. The lack of a standard taxonomy hinders the development of cumulative science in adherence research. This article reviews the newly established Ascertaining Barriers to Compliance (ABC) taxonomy for medication adherence with a particular focus on its relevance and applicability within the context of asthma and chronic obstructive pulmonary disease management. Building on traditional definitions and concepts within medication adherence, the ABC taxonomy considers the temporal sequence of steps a patient must undertake to be defined as "adherent to treatment": (A) initiation, (B) implementation, and (C) persistence. We explain the clinical and research relevance of differentiating between these phases, point to differences in its applicability in observational and experimental research, review strengths and limitations of available measures, and highlight recent findings on specific determinants of these behaviors. Finally, we provide recommendations for research and practice with a view to supporting and sign posting opportunities to improve future respiratory medication adherence and associated research.
DOI: 10.1016/j.jaip.2016.05.019
PubMed: 27587314
Links to Exploration step
pubmed:27587314Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">What We Mean When We Talk About Adherence in Respiratory Medicine.</title><author><name sortKey="Vrijens, Bernard" sort="Vrijens, Bernard" uniqKey="Vrijens B" first="Bernard" last="Vrijens">Bernard Vrijens</name><affiliation><nlm:affiliation>WestRock Healthcare, Visé, Belgium; Department of Public Health, University of Liège, Liège, Belgium. Electronic address: bernard.vrijens@westrock.com.</nlm:affiliation></affiliation></author><author><name sortKey="Dima, Alexandra L" sort="Dima, Alexandra L" uniqKey="Dima A" first="Alexandra L" last="Dima">Alexandra L. Dima</name><affiliation><nlm:affiliation>Amsterdam School of Communication Research ASCoR, University of Amsterdam, Amsterdam, The Netherlands.</nlm:affiliation></affiliation></author><author><name sortKey="Van Ganse, Eric" sort="Van Ganse, Eric" uniqKey="Van Ganse E" first="Eric" last="Van Ganse">Eric Van Ganse</name><affiliation><nlm:affiliation>Pharmaco-Epidemiology Lyon (PEL), HESPER, Claude Bernard University, Lyon, France; Respiratory Medicine, Croix-Rousse University Hospital, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Van Boven, Job F M" sort="Van Boven, Job F M" uniqKey="Van Boven J" first="Job F M" last="Van Boven">Job F M. Van Boven</name><affiliation><nlm:affiliation>Department of Primary Care, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</nlm:affiliation></affiliation></author><author><name sortKey="Eakin, Michelle N" sort="Eakin, Michelle N" uniqKey="Eakin M" first="Michelle N" last="Eakin">Michelle N. Eakin</name><affiliation><nlm:affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, Md.</nlm:affiliation></affiliation></author><author><name sortKey="Foster, Juliet M" sort="Foster, Juliet M" uniqKey="Foster J" first="Juliet M" last="Foster">Juliet M. Foster</name><affiliation><nlm:affiliation>Woolcock Institute of Medical Research, Clinical Management Group, University of Sydney, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="De Bruin, Marijn" sort="De Bruin, Marijn" uniqKey="De Bruin M" first="Marijn" last="De Bruin">Marijn De Bruin</name><affiliation><nlm:affiliation>Amsterdam School of Communication Research ASCoR, University of Amsterdam, Amsterdam, The Netherlands; Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Chisholm, Alison" sort="Chisholm, Alison" uniqKey="Chisholm A" first="Alison" last="Chisholm">Alison Chisholm</name><affiliation><nlm:affiliation>Respiratory Effectiveness Group, Cambridge, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Price, David" sort="Price, David" uniqKey="Price D" first="David" last="Price">David Price</name><affiliation><nlm:affiliation>Respiratory Effectiveness Group, Cambridge, UK; Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2016 Sep-Oct</MedlineDate></PubDate></date><idno type="RBID">pubmed:27587314</idno><idno type="pmid">27587314</idno><idno type="doi">10.1016/j.jaip.2016.05.019</idno><idno type="wicri:Area/PubMed/Corpus">001878</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001878</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">What We Mean When We Talk About Adherence in Respiratory Medicine.</title><author><name sortKey="Vrijens, Bernard" sort="Vrijens, Bernard" uniqKey="Vrijens B" first="Bernard" last="Vrijens">Bernard Vrijens</name><affiliation><nlm:affiliation>WestRock Healthcare, Visé, Belgium; Department of Public Health, University of Liège, Liège, Belgium. Electronic address: bernard.vrijens@westrock.com.</nlm:affiliation></affiliation></author><author><name sortKey="Dima, Alexandra L" sort="Dima, Alexandra L" uniqKey="Dima A" first="Alexandra L" last="Dima">Alexandra L. Dima</name><affiliation><nlm:affiliation>Amsterdam School of Communication Research ASCoR, University of Amsterdam, Amsterdam, The Netherlands.</nlm:affiliation></affiliation></author><author><name sortKey="Van Ganse, Eric" sort="Van Ganse, Eric" uniqKey="Van Ganse E" first="Eric" last="Van Ganse">Eric Van Ganse</name><affiliation><nlm:affiliation>Pharmaco-Epidemiology Lyon (PEL), HESPER, Claude Bernard University, Lyon, France; Respiratory Medicine, Croix-Rousse University Hospital, Lyon, France.</nlm:affiliation></affiliation></author><author><name sortKey="Van Boven, Job F M" sort="Van Boven, Job F M" uniqKey="Van Boven J" first="Job F M" last="Van Boven">Job F M. Van Boven</name><affiliation><nlm:affiliation>Department of Primary Care, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</nlm:affiliation></affiliation></author><author><name sortKey="Eakin, Michelle N" sort="Eakin, Michelle N" uniqKey="Eakin M" first="Michelle N" last="Eakin">Michelle N. Eakin</name><affiliation><nlm:affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, Md.</nlm:affiliation></affiliation></author><author><name sortKey="Foster, Juliet M" sort="Foster, Juliet M" uniqKey="Foster J" first="Juliet M" last="Foster">Juliet M. Foster</name><affiliation><nlm:affiliation>Woolcock Institute of Medical Research, Clinical Management Group, University of Sydney, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="De Bruin, Marijn" sort="De Bruin, Marijn" uniqKey="De Bruin M" first="Marijn" last="De Bruin">Marijn De Bruin</name><affiliation><nlm:affiliation>Amsterdam School of Communication Research ASCoR, University of Amsterdam, Amsterdam, The Netherlands; Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Chisholm, Alison" sort="Chisholm, Alison" uniqKey="Chisholm A" first="Alison" last="Chisholm">Alison Chisholm</name><affiliation><nlm:affiliation>Respiratory Effectiveness Group, Cambridge, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Price, David" sort="Price, David" uniqKey="Price D" first="David" last="Price">David Price</name><affiliation><nlm:affiliation>Respiratory Effectiveness Group, Cambridge, UK; Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK.</nlm:affiliation></affiliation></author></analytic><series><title level="j">The journal of allergy and clinical immunology. In practice</title><idno type="eISSN">2213-2201</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Asthma (drug therapy)</term><term>Humans</term><term>Medication Adherence</term><term>Pulmonary Disease, Chronic Obstructive (drug therapy)</term><term>Pulmonary Medicine (classification)</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Pulmonary Medicine</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Asthma</term><term>Pulmonary Disease, Chronic Obstructive</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Medication Adherence</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Adequate medication adherence is key for optimal benefit of pharmacological treatments. A wealth of research has been conducted to understand and identify opportunities to intervene to improve medication adherence, but variations in adherence definitions within prior research have led to ambiguity in study findings. The lack of a standard taxonomy hinders the development of cumulative science in adherence research. This article reviews the newly established Ascertaining Barriers to Compliance (ABC) taxonomy for medication adherence with a particular focus on its relevance and applicability within the context of asthma and chronic obstructive pulmonary disease management. Building on traditional definitions and concepts within medication adherence, the ABC taxonomy considers the temporal sequence of steps a patient must undertake to be defined as "adherent to treatment": (A) initiation, (B) implementation, and (C) persistence. We explain the clinical and research relevance of differentiating between these phases, point to differences in its applicability in observational and experimental research, review strengths and limitations of available measures, and highlight recent findings on specific determinants of these behaviors. Finally, we provide recommendations for research and practice with a view to supporting and sign posting opportunities to improve future respiratory medication adherence and associated research.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27587314</PMID><DateCreated><Year>2016</Year><Month>09</Month><Day>02</Day></DateCreated><DateCompleted><Year>2017</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2017</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2213-2201</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>5</Issue><PubDate><MedlineDate>2016 Sep-Oct</MedlineDate></PubDate></JournalIssue><Title>The journal of allergy and clinical immunology. In practice</Title><ISOAbbreviation>J Allergy Clin Immunol Pract</ISOAbbreviation></Journal><ArticleTitle>What We Mean When We Talk About Adherence in Respiratory Medicine.</ArticleTitle><Pagination><MedlinePgn>802-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaip.2016.05.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2198(16)30158-1</ELocationID><Abstract><AbstractText>Adequate medication adherence is key for optimal benefit of pharmacological treatments. A wealth of research has been conducted to understand and identify opportunities to intervene to improve medication adherence, but variations in adherence definitions within prior research have led to ambiguity in study findings. The lack of a standard taxonomy hinders the development of cumulative science in adherence research. This article reviews the newly established Ascertaining Barriers to Compliance (ABC) taxonomy for medication adherence with a particular focus on its relevance and applicability within the context of asthma and chronic obstructive pulmonary disease management. Building on traditional definitions and concepts within medication adherence, the ABC taxonomy considers the temporal sequence of steps a patient must undertake to be defined as "adherent to treatment": (A) initiation, (B) implementation, and (C) persistence. We explain the clinical and research relevance of differentiating between these phases, point to differences in its applicability in observational and experimental research, review strengths and limitations of available measures, and highlight recent findings on specific determinants of these behaviors. Finally, we provide recommendations for research and practice with a view to supporting and sign posting opportunities to improve future respiratory medication adherence and associated research.</AbstractText><CopyrightInformation>Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vrijens</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>WestRock Healthcare, Visé, Belgium; Department of Public Health, University of Liège, Liège, Belgium. Electronic address: bernard.vrijens@westrock.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dima</LastName><ForeName>Alexandra L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Amsterdam School of Communication Research ASCoR, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Ganse</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pharmaco-Epidemiology Lyon (PEL), HESPER, Claude Bernard University, Lyon, France; Respiratory Medicine, Croix-Rousse University Hospital, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Boven</LastName><ForeName>Job F M</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Primary Care, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eakin</LastName><ForeName>Michelle N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, Md.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foster</LastName><ForeName>Juliet M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Woolcock Institute of Medical Research, Clinical Management Group, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Bruin</LastName><ForeName>Marijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Amsterdam School of Communication Research ASCoR, University of Amsterdam, Amsterdam, The Netherlands; Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chisholm</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Respiratory Effectiveness Group, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Price</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Respiratory Effectiveness Group, Cambridge, UK; Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Allergy Clin Immunol Pract</MedlineTA><NlmUniqueID>101597220</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055118" MajorTopicYN="Y">Medication Adherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015272" MajorTopicYN="N">Pulmonary Medicine</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ABC taxonomy</Keyword><Keyword MajorTopicYN="N">Asthma</Keyword><Keyword MajorTopicYN="N">Chronic obstructive pulmonary disease (COPD)</Keyword><Keyword MajorTopicYN="N">Implementation</Keyword><Keyword MajorTopicYN="N">Initiation</Keyword><Keyword MajorTopicYN="N">Medication adherence</Keyword><Keyword MajorTopicYN="N">Persistence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>02</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>05</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>05</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27587314</ArticleId><ArticleId IdType="pii">S2213-2198(16)30158-1</ArticleId><ArticleId IdType="doi">10.1016/j.jaip.2016.05.019</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001878 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001878 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:27587314
|texte= What We Mean When We Talk About Adherence in Respiratory Medicine.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27587314" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |